Stay updated on PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial
Sign up to get notified when there's something new on the PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial page.

Latest updates to the PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial page
- Check6 days agoChange DetectedRevision metadata updated from v3.4.2 to v3.4.3. No trial details or user-facing information were changed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAddition: Revision: v3.4.2; Deletions: removal of the long government funding lapse notice and the older Revision: v3.4.1 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedA government funding status notice was added and the site revision updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check48 days agoChange DetectedThe page now includes a Show glossary option and new metadata fields such as 'Results First Posted' and 'Last Update Posted'/'Last Update Submitted that Met QC Criteria', along with the No FEAR Act Data notice and Revision: v3.4.0. Removed older fields and the previous revision label (v3.3.4).SummaryDifference0.3%

- Check62 days agoChange DetectedRevision: v3.3.4 was added, replacing the previous v3.3.3.SummaryDifference0.1%

- Check84 days agoChange DetectedThe per-state 'Locations' headings have been replaced with a single consolidated 'Locations' section listing study sites by state (Arizona, California, Georgia, Kansas, Massachusetts, Mississippi, New Jersey, New York, Pennsylvania, Tennessee, Texas). Revision: v3.3.3 is now shown, indicating an updated version since v3.3.2.SummaryDifference1%

Stay in the know with updates to PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PH94B Nasal Spray Efficacy in Public Speaking Clinical Trial page.